Abating pressure overload by hydralazine, blockade of AT2 receptor with the AT2 antagonist PD123319 or deletion of AT2(Agtr2-/Y) prevents cardiac hypertrophy. The gene discussed is AGTR2; the disease is cardiac hypertrophy.